Browsing by Yonsei Author : Kim, Jin Seok

Name:
Kim, Jin Seok [김진석] http://orcid.org/0000-0001-8986-8436
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
(55032033600)

Keyword Cloud

Researcher Network

Showing results 1 to 50 of 186

This table browses all dspace content
Issue DateTitleJournal Title
2021Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin's lymphoma KOREAN JOURNAL OF INTERNAL MEDICINE
2020Increasing Incidence of B-Cell Non-Hodgkin Lymphoma and Occurrence of Second Primary Malignancies in South Korea: 10-Year Follow-up Using the Korean National Health Information Database CANCER RESEARCH AND TREATMENT
2020Immunosuppressive role of CD11b + CD33 + HLA-DR - myeloid-derived suppressor cells-like blast subpopulation in acute myeloid leukemia CANCER MEDICINE
2020Upfront autologous hematopoietic stem cell transplantation for high-risk patients with double-expressor diffuse large B cell lymphomaANNALS OF HEMATOLOGY
2020Association between sexuality knowledge and sexual dysfunction in hematopoietic stem cell transplantation patients and their partnersPATIENT EDUCATION AND COUNSELING
2020Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)BONE MARROW TRANSPLANTATION
2020Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era SCIENTIFIC REPORTS
2020Autologous stem cell transplantation in elderly patients with multiple myeloma in Korea: the KMM1807 studyINTERNATIONAL JOURNAL OF HEMATOLOGY
2020Serum albumin and C-reactive protein as significant predictors of non-relapse mortality in lower gastrointestinal graft-versus-host diseaseANNALS OF HEMATOLOGY
2020ULK1 Inhibition as a Targeted Therapeutic Strategy for FLT3-ITD-mutated Acute Myeloid Leukemia JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
2020Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30-Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial CANCER RESEARCH AND TREATMENT
2020PERK/NRF2 and Autophagy Form a Resistance Mechanism Against G9a Inhibition in Leukemia Stem Cells JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
2020The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuriaBLOOD
2019Clinical Implication of Renal Dysfunction During the Clinical Course in Patients With Paroxysmal Nocturnal Hemoglobinuria: A Longitudinal AnalysisANNALS OF HEMATOLOGY
2019후천성 혈우병 A Clinical and Experimental Thrombosis and Hemostasis
2019국소적 대상포진이 발생한 면역저하환자로부터 유발된 수두의 발생 Korean Journal of Nosocomial Infection Control (병원감염관리)
2019Early Cytomegalovirus Reactivation and Expansion of CD56brightCD16dim/-DNAM1+ Natural Killer Cells Are Associated with Antileukemia Effect after Haploidentical Stem Cell Transplantation in Acute LeukemiaBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
2019Induction of apoptosis and differentiation by Na/H exchanger 1 modulation in acute myeloid leukemia cellsBIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
2019A Phase I/II, Open-Label, Prospective, Multicenter Study to Evaluate the Efficacy and Safety of Lower Doses of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients with Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation: The KMM103 StudyBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
2019Long-term outcome, relapse patterns, and toxicity after radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma: implications for radiotherapy optimizationJapanese Journal of Clinical Oncology
2018Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150)BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
2018HBsAg-Negative, Anti-HBc-Negative Patients Still Have a Risk of Hepatitis B Virus-Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma CANCER RESEARCH AND TREATMENT
2018A prognostic scoring system for patients with multiple myeloma classified as stage II with the Revised International Staging SystemBRITISH JOURNAL OF HAEMATOLOGY
2017Comprehensive Evaluation of the Revised International Staging System in Multiple Myeloma Patients Treated with Novel Agents as a Primary TherapyAMERICAN JOURNAL OF HEMATOLOGY
2017Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trial.LANCET HAEMATOLOGY
2017Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study.LEUKEMIA
2017A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma ONCOTARGET
2017Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma ONCOTARGET
2017Clinical impact of early recovery of peripheral blood absolute lymphocyte count after frontline autologous stem cell transplantation for diffuse large B-cell lymphomaHEMATOLOGICAL ONCOLOGY
2017Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma ONCOTARGET
2017The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: a retrospective multicenter study (KMM160) ONCOTARGET
2017Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trial BLOOD RESEARCH
2017Programmed cell death 1 expression is associated with inferior survival in patients with primary central nervous system lymphoma ONCOTARGET
2017Efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria patients with or without aplastic anemia: prospective study of a Korean PNH cohort BLOOD RESEARCH
2017Clinical characteristics and treatment outcomes of isolated myeloid sarcoma without bone marrow involvement: a single-institution experience BLOOD RESEARCH
2017Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" StudyBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
2017Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation RADIATION ONCOLOGY JOURNAL
2017Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scoresANNALS OF HEMATOLOGY
2017Hematopoietic stem cell mobilization: current status and future perspective BLOOD RESEARCH
2017내과 전문의 시험제도의 발전방향 Korean Journal of Medicine
2017Long-Term Follow-Up of Patients After Autologous Bone Marrow Cell Infusion for Decompensated Liver Cirrhosis CELL TRANSPLANTATION
2017Prognostic significance of interventricular septal thickness in patients with AL amyloidosisLEUKEMIA RESEARCH
2017AMPK-ULK1-Mediated Autophagy Confers Resistance to BET Inhibitor JQ1 in Acute Myeloid Leukemia Stem CellsCLINICAL CANCER RESEARCH
2017Decitabine as a First-Line Treatment for Older Adults Newly Diagnosed with Acute Myeloid Leukemia YONSEI MEDICAL JOURNAL
2017Targeting AMPK-ULK1-mediated autophagy for combating BET inhibitor resistance in acute myeloid leukemia stem cells.AUTOPHAGY
2017The prognostic role of CD68 and FoxP3 expression in patients with primary central nervous system lymphomaANNALS OF HEMATOLOGY
2016Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen BMC CANCER
2016A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysisLANCET ONCOLOGY
2016Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemiaANNALS OF ONCOLOGY
2016Bendamustine in heavily pre-treated multiple myeloma patients: Results of a retrospective analysis from the Korean Multiple Myeloma Working Party BLOOD RESEARCH

Browse

Links